Kandy Therapeutics Limited

Calculating rank

USPTO Granted Patents = 6

EPO Patents = 2

Forward Citations = 18

Loading Chart...

8 inventors (with patents filed for the assignee):

Mike Trower (5 out of 9 patents)

Monica Lazaro (5 out of 5 patents)

Derek Bush (5 out of 5 patents)

4. David Elder (5 out of 7 patents)

5. Mary Kerr (5 out of 6 patents)

6. Marcel Schleusner (1 out of 6 patents)

7. Massimo Ghizzoni (1 out of 1 patent)

8. Ron Lawrence (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12473260 - Chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814 (2025-11-18),

2. 12264164 - Method of treatment of symptoms of menopause (2025-04-01),

3. 11787820 - Method of treating certain sex hormone-dependent diseases administering a soft gelatin capsule comprising NK1 and NK3 receptors antagonists (2023-10-17),

4. 11767328 - Method of treatment of symptoms of menopause (2023-09-26),

5. 11591346 - Method of treatment of symptoms of menopause (2023-02-28),

6. 10774091 - Soft gelatin capsule formulation (2020-09-15),

Company Overview

Kandy Therapeutics Limited is a biopharmaceutical company focused on developing novel therapies for the treatment of chronic and debilitating diseases. With a dedicated team of researchers and scientists, Kandy Therapeutics is committed to advancing innovative treatments that improve the quality of life for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

6 Patents

#8 in Stevenage

#2,683 in United Kingdom

Stevenage, United Kingdom

Kandy Therapeutics Limited

Forward Citations = 18

8 inventors:

Mike Trower (5 out of 9 patents)

Monica Lazaro (5 out of 5 patents)

Derek Bush (5 out of 5 patents)

4. David Elder (5 out of 7 patents)

5. Mary Kerr (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kandy Therapeutics Limited. Retrieved from https://idiyas.com/company/kandy-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]